Does UPADACITINIB Cause Deafness? 118 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 118 reports of Deafness have been filed in association with UPADACITINIB (Rinvoq). This represents 0.2% of all adverse event reports for UPADACITINIB.
118
Reports of Deafness with UPADACITINIB
0.2%
of all UPADACITINIB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Deafness From UPADACITINIB?
Of the 118 reports, 10 (8.5%) required hospitalization.
Is Deafness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 118 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Deafness?
ADALIMUMAB (1,300)
METHOTREXATE (635)
ETANERCEPT (629)
SACUBITRIL\VALSARTAN (471)
APIXABAN (455)
LENALIDOMIDE (397)
TOFACITINIB (388)
CISPLATIN (344)
AMIKACIN (320)
ATORVASTATIN (308)
Which UPADACITINIB Alternatives Have Lower Deafness Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL